Farnesyl transferase inhibitors: current developments and future perspectives
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 26 (5) , 319-332
- https://doi.org/10.1053/ctrv.2000.0187
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Non-Ras targets of farnesyltransferase inhibitors: focus on RhoOncogene, 1998
- CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agentsTrends in Pharmacological Sciences, 1997
- THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICSAnnual Review of Pharmacology and Toxicology, 1997
- Farnesyltransferase inhibitors and anti-Ras therapyBreast Cancer Research and Treatment, 1996
- CAAX Peptidomimetic FTI-244 Decreases Platelet-Derived Growth Factor Receptor Tyrosine Phosphorylation Levels and Inhibits Stimulation of Phosphatidylinositol 3-Kinase but Not Mitogen-Activated Protein KinaseBiochemical and Biophysical Research Communications, 1995
- Farnesyl Diphosphate-Based Inhibitors of Ras Farnesyl Protein TransferaseJournal of Medicinal Chemistry, 1995
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- Inhibitors of ras farnesyltransferasesTrends in Biochemical Sciences, 1993
- Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal CellsScience, 1993
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993